CTNM
Financials
- Market Capitalization 398.23 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3065 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.05 USD | -0.49% | -2.88% | +1.00% | +36.36% | 401.54 M USD | ||
| 3067 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 14.09 USD | +4.29% | +0.28% | +10.94% | +55.52% | 410.38 M USD | ||
| 3097 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.78 USD | +1.70% | -3.82% | +15.18% | -0.21% | 392.18 M USD | ||
| 3110 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.11 USD | +3.94% | -1.86% | +2.93% | +348.94% | 382.07 M USD |
Frequently asked questions about Contineum Therapeutics, Inc. Class A Common Stock
What is the Contineum Therapeutics, Inc. Class A Common Stock stock price today?
The current price of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is 17.24. Over the past 24 hours, the stock has changed by +4.17%. Follow the CTNM chart for real-time price dynamics.
What is the stock ticker of Contineum Therapeutics, Inc. Class A Common Stock?
Contineum Therapeutics, Inc. Class A Common Stock trades under the ticker CTNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Contineum Therapeutics, Inc. Class A Common Stock stock going up?
CTNM has changed by +1.71% over the last week, +13.27% over the last month, and +12.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Contineum Therapeutics, Inc. Class A Common Stock?
Contineum Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 398.23 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Contineum Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, Contineum Therapeutics, Inc. Class A Common Stock reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Contineum Therapeutics, Inc. Class A Common Stock net income for the last quarter?
Contineum Therapeutics, Inc. Class A Common Stock reported net income of -15.15 M for the last quarter. The previous quarter showed -14.46 M, which means net income changed by -4.83%.
How many employees does Contineum Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, Contineum Therapeutics, Inc. Class A Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Contineum Therapeutics, Inc. Class A Common Stock stock?
You can buy Contineum Therapeutics, Inc. Class A Common Stock (CTNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Contineum Therapeutics, Inc. Class A Common Stock stock?
Investing in Contineum Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTNM chart and related analysis on metatrader.com as part of your research.